fluorodeoxyglucose f18 has been researched along with amyloid beta-peptides in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borroni, B; Di Luca, M; Padovani, A; Premi, E | 1 |
| Arbuckle, M; Baker, LD; Callaghan, M; Claxton, A; Craft, S; Cross, D; Gerton, B; Green, PS; Leverenz, J; Minoshima, S; Montine, TJ; Plymate, SR; Tsai, E; Watson, GS | 1 |
| Chen, K; Huang, Q; Li, C; Li, G; Li, X; Lin, Z; Reiman, EM; Wang, T; Xiao, S | 1 |
| Ayrignac, X; Azakri, S; Boukriche, Y; Charif, M; Chiper, L; Collombier, L; Fourcade, G; Gaillard, N; Lehmann, S; Mercier, E; Renard, D; Tatu, L; Thouvenot, E; Wacongne, A | 1 |
| Arbizu, J; Boada, M; Martínez-Lage, P; Monleón, I; Munuera, J; Pérez-Grijalba, V; Pesini, P; Romero, J; Ruiz, A; San-José, I; Sarasa, L; Sarasa, M; Tárraga, L | 1 |
| Cai, Q; Huang, G; Li, W; Li, Z; Liu, W; Meng, X; Wang, S; Zhang, D; Zhang, X; Zhang, Y; Zheng, Y | 1 |
| Hong, JH; Ji, HD; Kim, HW; Kim, S; Lee, JI; Lee, SW; Lim, JS; Song, BI; Won, KS | 1 |
| Cai, HC; Cheng, DF; Han, YJ; Lei, B; Wang, J; Wu, MX; Yin, DZ; Zhang, H; Zhang, L; Zheng, MQ | 1 |
1 review(s) available for fluorodeoxyglucose f18 and amyloid beta-peptides
| Article | Year |
|---|---|
Combined biomarkers for early Alzheimer disease diagnosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition Disorders; Fluorodeoxyglucose F18; Humans; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Proteome; Serum Amyloid A Protein; tau Proteins | 2007 |
2 trial(s) available for fluorodeoxyglucose f18 and amyloid beta-peptides
| Article | Year |
|---|---|
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Topics: Administration, Intranasal; Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, Veterans; Humans; Hypoglycemic Agents; Immunoassay; Insulin; Least-Squares Analysis; Male; Neuropsychological Tests; Peptide Fragments; Pilot Projects; Positron-Emission Tomography; Psychiatric Status Rating Scales; Spinal Puncture; tau Proteins | 2012 |
Effects of memantine on clinical ratings, fluorodeoxyglucose positron emission tomography measurements, and cerebrospinal fluid assays in patients with moderate to severe Alzheimer dementia: a 24-week, randomized, clinical trial.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Chi-Square Distribution; China; Cognition; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Humans; Male; Memantine; Middle Aged; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Radiopharmaceuticals; Severity of Illness Index; tau Proteins; Time Factors; Treatment Outcome | 2013 |
5 other study(ies) available for fluorodeoxyglucose f18 and amyloid beta-peptides
| Article | Year |
|---|---|
Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Apolipoproteins E; Cerebral Amyloid Angiopathy; Cerebral Hemorrhage; Cohort Studies; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; ROC Curve; tau Proteins; Vasculitis | 2018 |
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Early Diagnosis; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Neuroimaging; Peptide Fragments; Phosphorylation; Plaque, Amyloid; Positron-Emission Tomography; Prodromal Symptoms; tau Proteins; Thiazoles | 2019 |
Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPARγ-dependent activation of PGC-1α/GLUT4 signalling in APP/PS1 transgenic mice.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Anilides; Animals; Behavior, Animal; Brain; Cytokines; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 4; Hippocampus; Immunologic Factors; Mice; Mice, Transgenic; Morris Water Maze Test; Neurons; Peptide Fragments; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Positron-Emission Tomography; PPAR gamma; Presenilin-1; Prostaglandin D2; Radiopharmaceuticals; Signal Transduction | 2021 |
Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Carotid Arteries; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Hippocampus; Male; Maze Learning; Peptide Fragments; Positron-Emission Tomography; Rats; Rats, Wistar; tau Proteins | 2022 |
Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
Topics: Algorithms; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Diagnostic Imaging; Disease Models, Animal; Fluorodeoxyglucose F18; Hippocampus; Male; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Thalamus; Thiazoles; Tissue Distribution | 2008 |